The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Once a day dosage of Simeprevir for patients has shown that it is safe to take and, thus far, has very little drug interactions. As such a complex disease, those with Hepatitis C need many medication and treatment options so that they may have a chance at recovery.
Continue reading »A new report warns the international community of the hazardous relationship between Hepatitis C infection and the criminalization of drugs.
Continue reading »Those with Hepatitis C need to know about the research where this liver virus was found in carotid artery plaques – and what that means to them.
Continue reading »Researchers are attempting to create a version of bilirubin, a fluid made by our liver – and also found in unagi eels – because it may help treat liver disease.
Continue reading »A new test has been designed by Abbot Laboratories that can single out seven different varieties of Hepatitis C.
Continue reading »Before starting clinical evaluations, the FDA demands more safety data on Idenix Pharmaceuticals’ new drug.
Continue reading »
Proving the virus can survive in a syringe for up to 63 days, research demonstrates three different characteristics that make Hepatitis C transmission viable from a needle.
Continue reading »
Although relatively rare, learn 12 facts about babies born with Hepatitis C.
Continue reading »An interferon-free drug trial for Hepatitis C is now accepting treatment naïve participants in Florida.
Continue reading »Korean researchers have developed RNA aptamers, potential drug agents that appear to prevent the persistent problem of Hepatitis C antiviral drug resistance.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
